Please login to the form below

Not currently logged in
Email:
Password:

patients

This page shows the latest patients news and features for those working in and with pharma, biotech and healthcare.

Quick Change

Quick Change

I was encouraging it to adopt contextual segmentation. In this approach (see PME April 2012) the heterogeneity of patients, payers and professionals is combined to understand the market in terms of ... When given a new product, the field teams were

Latest news

  • Biogen and Eisai pull plug on Alzheimer’s drug Biogen and Eisai pull plug on Alzheimer’s drug

    The partners have a similar candidate, BAN2401, being studied in prodromal and mild Alzheimer’s patients, though its future must now also be under review. ... pipeline of potential therapies in Alzheimer’s disease and innovative medicines for

  • Novo uses voucher for speedy answer on oral semaglutide Novo uses voucher for speedy answer on oral semaglutide

    Known for now as oral semaglutide, the once-daily glucagon-like peptide-1 (GLP-1) analogue tablet is highly anticipated, as its patient-friendly formulation could see it dominate in the

  • Amgen, Servier heart failure drug clears trial hurdle Amgen, Servier heart failure drug clears trial hurdle

    GALACTIC-HF is comparing omecamtiv with placebo when added to current heart failure standard treatment in patients with chronic heart failure and reduced ejection fraction (HFrEF), which occurs when the left ... Last month, Amgen and Servier said they

  • Is Orkambi deal close? Vertex meets again today with NHS England Is Orkambi deal close? Vertex meets again today with NHS England

    The long running row has seen patient campaigners take to the streets and social media to protest, putting pressure on both sides to come to an agreement. ... The CF Trust believes that some sort of outcomes-based deal, drawing on its own registry of CF

  • Pfizer hedges bets on gene therapy deal Pfizer hedges bets on gene therapy deal

    Pfizer's rare disease leader Seng Cheng. “VTX-801 could provide a potentially transformative therapeutic option for patients with Wilson disease by directly addressing the underlying cause of the disease—the

More from news
Approximately 205 fully matching, plus 5,866 partially matching documents found.

Latest Intelligence

  • Measures for measures Measures for measures

    The benefits could be significant. “Meeting crude tactical KPIs may make you look good at your next appraisal, but are the outcomes as impressive in the crucial arena of patient care?” ... Ultimately, everything comes down to patient value and purpose

  • Where next in Alzheimer’s disease R&D? Where next in Alzheimer’s disease R&D?

    In parallel, diagnostic groups are working to improve the detection and stratification of Alzheimer’s patients. ... When coupled to improved patient selection, that advance could be significant enough to finally yield a breakthrough.

  • Brain power: fresh approaches to Alzheimer’s drug discovery Brain power: fresh approaches to Alzheimer’s drug discovery

    This allows a greater proportion of patients to potentially benefit from new therapies. ... goal of helping patients all over the world who suffer from debilitating central nervous system disorders.”.

  • Genomics integration: can the NHS rise to the challenge? Genomics integration: can the NHS rise to the challenge?

    We want to ensure that every patient has the opportunity to have a genomic test if deemed appropriate by their clinician.”. ... The data has to be managed very carefully, with the benefits and limitations made easy to understand for patients.

  • Bringing life to precision medicine Bringing life to precision medicine

    This information is then cross-referenced with existing databases that contain large amounts of aggregated data from other patients to identify which drug should work for that patient. ... A groundbreaking study in 2018 on patients with recurrent

More from intelligence
Approximately 87 fully matching, plus 714 partially matching documents found.

Latest appointments

  • New faces at 11 London, ramarketing and MSL New faces at 11 London, ramarketing and MSL

    Experience tells me that wellbeing and digital innovation is critical to success, so you can evidence campaign impact, while engaging and involving patients. ... With expertise in strategic communications, multi-stakeholder engagement and patient

  • Streaming Well to “raise the bar in pharma film making” Streaming Well to “raise the bar in pharma film making”

    Together, our mission is to raise the bar on what HCP and patient engagement looks like for the healthcare industry through powerful storytelling and interactive experiences.

  • New faces at imc, GCI Health and Lighthouse US New faces at imc, GCI Health and Lighthouse US

    Additionally, she has also served as a member of the board of management of the ABPI, where she championed access and funding for patients with rare diseases. ... healthcare communications, with a clear focus on improving patients’ lives.

  • New hires at Ferring, Flexion and Immunocore New hires at Ferring, Flexion and Immunocore

    It’s the first major appointment for Ferring in 2019, and the company says Opdyke will lead the potential commercial launch of its investigational gene therapy for bladder cancer patients in ... By unlocking the T cell receptor with its leading

  • New faces at Lucid, 90Ten and Page & Page New faces at Lucid, 90Ten and Page & Page

    Ruth McIntyre joins 90Ten Communications from Galliard, where she delivered patients education and corporate change management initiatives. ... I’m looking forward to being part of such a pioneering business where everything really is about improving

More from appointments
Approximately 2 fully matching, plus 451 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 217 fully matching, plus 884 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Healthcircle

We're Healthcircle – an award-winning healthcare advertising and creative communications agency, offering a holistic approach to brand health. With a...

Latest intelligence

Mobilising the public to combat the antimicrobial resistance crisis
Antimicrobial resistance is one of the greatest threats to human health, according to the World Health Organisation. So why doesn’t the public seem bothered? BLH Account Executive Ford Stewart examines...
Measures for measures
Why pharma’s marketing metrics must close the loop...
Where next in Alzheimer’s disease R&D?
How past failures and emerging biology are reshaping drug development...

Infographics